Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses

Hum Gene Ther. 2002 Sep 1;13(13):1571-81. doi: 10.1089/10430340260201662.

Abstract

Oral vaccines can induce both systemic and mucosal immunity. Mucosal immunity, especially regional cell-mediated immunity, plays an important role in protecting individuals from infectious diseases such as acquired immunodeficiency syndrome. In this study, a recombinant adeno-associated virus vector expressing human immunodeficiency virus type 1 env gene (AAV-HIV) was orally administered to BALB/c mice. Systemic and regional immunity was induced in the mice. Furthermore, the immunization significantly reduced viral load after an intrarectal challenge with a recombinant vaccinia virus expressing HIV env gene. Moreover, we also show that dendritic cells might contribute to the AAV-HIV vector-induced immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / genetics
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / prevention & control*
  • Administration, Oral
  • Animals
  • Dependovirus*
  • Gene Products, env / genetics*
  • Gene Products, env / immunology
  • Genetic Vectors*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Immunity, Mucosal / genetics
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / genetics

Substances

  • AIDS Vaccines
  • Gene Products, env
  • Vaccines, Synthetic